RENOVARO INC. - COMMON STOCK

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17 10 2024 09:15:17 提供 Nasdaq GlobeNewswire

Renovaro Announces Strategic Restructuring and Leadership Transition

16 10 2024 09:28:06 提供 Nasdaq GlobeNewswire

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

19 9 2024 09:00:00 提供 Nasdaq GlobeNewswire

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

17 9 2024 09:00:00 提供 Nasdaq GlobeNewswire

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

13 9 2024 09:00:00 提供 Nasdaq GlobeNewswire

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

11 9 2024 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro, Inc. Announces $10 million in Equity Committed

14 6 2024 09:06:00 提供 Nasdaq GlobeNewswire

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

24 5 2024 09:20:00 提供 Nasdaq GlobeNewswire

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

30 4 2024 11:00:00 提供 Nasdaq GlobeNewswire

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

24 4 2024 09:00:00 提供 Nasdaq GlobeNewswire

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care

18 4 2024 08:45:00 提供 Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

15 2 2024 09:25:00 提供 Nasdaq GlobeNewswire

Statement of Renovaro Inc

14 2 2024 10:01:30 提供 Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

13 2 2024 09:46:07 提供 Nasdaq GlobeNewswire

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

13 2 2024 09:31:09 提供 Nasdaq GlobeNewswire

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

25 1 2024 12:45:00 提供 Nasdaq GlobeNewswire

Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD

16 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

11 10 2023 09:25:00 提供 Nasdaq GlobeNewswire

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

10 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

02 10 2023 12:05:40 提供 Nasdaq GlobeNewswire